Shizuoka, Japan

Nobuhiro Ohi


Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 19(Granted Patents)


Location History:

  • Tokyo, JP (1987)
  • Shizuoka, JP (1994 - 1999)

Company Filing History:


Years Active: 1987-1999

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Nobuhiro Ohi: Innovator in Pharmaceutical Chemistry

Introduction

Nobuhiro Ohi is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating ischemic diseases. With a total of 4 patents to his name, Ohi's work has the potential to impact medical treatments significantly.

Latest Patents

Ohi's latest patents include innovative compounds such as benzene derivatives, which are designed for treating ischemic conditions. One of his notable inventions is a compound represented by a specific formula, where various groups are defined to enhance its efficacy. This compound exhibits an inhibitory action on calcium overload and lipid peroxidation, making it a valuable candidate for preventing and treating ischemic diseases and hypertension. Another significant patent involves a methotrexate derivative, further showcasing his expertise in pharmaceutical innovations.

Career Highlights

Nobuhiro Ohi is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His work at Chugai has allowed him to focus on developing novel therapeutic agents that address critical health issues. Ohi's dedication to research and innovation has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Ohi has collaborated with notable colleagues such as Takashi Mori and Yoshiyuki Ohsugi. These partnerships have facilitated the exchange of ideas and expertise, contributing to the advancement of their collective research efforts.

Conclusion

Nobuhiro Ohi's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a significant inventor in the field. His work continues to pave the way for new treatments that can improve patient outcomes in ischemic diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…